Articles

Therapy offers beneficial weight loss in treatment of diabetes, but which agent in the class leads to the greatest body weight reduction?

Diabetes-status in older Americans can lead experts in establishing an association between cognitive impairment and mortality.

Protecting the heart and helping to reduce mortality, a closer look at beta-adrenoceptor inhibition in diabetes.

Subtle elevations in fasting glucose and triglycerides associated with developing type 2 diabetes.

Study conducted in Germany demonstrates all-cause mortality to be doubled in patients with both diagnosed and undiagnosed type 2 diabetes.

Meta-analysis explores safety and efficacy of sodium-glucose co-transporter 2 inhibitors in patients with type 1 diabetes.

Females with breast cancer and diabetes have poorer prognosis than those with breast cancer without diabetes, but why?

Although the risk of end-stage renal disease remains high for individuals with type 1 diabetes, lifetime likelihood of ESRD has substantially decreased over the last 50 years.

Study in England links high HbA1c levels to long-term cognitive decline.

Insulin resistance has been proposed as one of the causes of poor glycemic control in youth with type 1 diabetes who have excess weight or obesity.